SAN DIEGO, March 17, 2017 -- The Bright Cell, a leading e-cigarette and vaping company in South Korea, has partnered with Next Generation Labs to captivate the growing female vape market in Korea with the October 2016 launch of its Scala e-liquid brand. Developed with Next Generation Labs’ TFN Nicotine® – a test-verified non-tobacco derived synthetic nicotine liquid – the Scala brand features a feminine design, and uses creative emotional branding to appeal to its targeted audience.
The Bright Cell representative Nayeon Kim comments, “Influences from Confucian culture have created a generally negative attitude toward female e-cigarette users in Korea. However, there has been a steady growth in female e-cigarette users in Korea, presenting the opportunity to shift the nation’s attitude toward women who vape. We launched the Scala brand to aid in creating a more positive attitude toward female e-cigarette users by offering a unique, feminine brand that women could feel good about using.”
The Bright Cell developed Scala with TFN Nicotine® due to the pure nature of the synthetic nicotine, which offers a cleaner vape experience. This complements the Scala brand, which promotes the enjoyment of daily life regardless of gender – in fact; the name Scala comes from the 'Teatro alla Scala', an Italian opera theater built in 1778, which is a metaphor of life as a stage for people.
The Scala e-liquid line features seven flavors, each of which are named after the emotions faced daily by every person, capturing the feelings of everyday life. The branding combines basic human emotions with the days of the week, creating a unique product that draws the attention of its users.
"The Korean market has faced many challenges as consumers have been mislead by unscrupulous companies using low-quality raw materials. The Bright Cell is proud to use TFN Nicotine in the Scala brand as we continue to develop our products with the highest quality ingredients to ensure our end-consumers have the best possible experience,” concludes Kim.
Vincent Schuman, CEO of Next Generation Labs adds, “The branding, flavors and satisfaction of Scala e-liquids have been extremely well received within the Korean market and we anticipate further success for The Bright Cell’s TFN brands in 2017."
About Next Generation Labs
Founded in 2014, Next Generation Labs developed TFN Nicotine®, the world’s leading synthetic nicotine that is not derived from tobacco. TFN Nicotine is used in over 40 e-liquid brands and is playing a central role in revolutionizing the e-cigarette and vaping industry.
www.nextgenerationlabs.com
Contacts Katie Ray [email protected] 973 570 6907


FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 



